Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000228535 | SCV000285228 | pathogenic | Tuberous sclerosis 2 | 2016-01-01 | criteria provided, single submitter | clinical testing | While this particular variant has not been reported in the literature, truncating variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This sequence change inserts 1 nucleotide in exon 12 of the TSC2 mRNA (c.1160dupT), causing a frameshift at codon 388. This creates a premature translational stop signal (p.Leu388Valfs*9) and is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. |